Caribou Biosciences (CRBU) Change in Cash (2020 - 2026)
Caribou Biosciences (CRBU) reported Change in Cash of -$303000.0 for Q1 2026, down 102.31% year-over-year from $13.1 million in Q1 2025, and down 124.92% on a QoQ basis from $1.2 million in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of Change in Cash data on file, last reported at -$303000.0 in Q1 2026.
- Quarterly Change in Cash fell 102.31% year-over-year to -$303000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.4 million (up 13.13% YoY) and the FY2025 annual result came in at -$3.9 million, up 88.72% from the prior year.
- Change in Cash retreated to -$303000.0 in Q1 2026 per CRBU's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $37.9 million in Q3 2023 and bottomed at -$92.8 million in Q1 2022.
- The 5-year median for Change in Cash is -$5.9 million (2024), against an average of -$13.4 million.
- The widest annual swing landed in 2024, when Change in Cash sank 185.75%; it then soared 844.84% in 2025.
- Tracing CRBU's Change in Cash over 5 years: stood at -$23.7 million in 2022, then sank by 122.75% to -$52.9 million in 2023, then surged by 70.36% to -$15.7 million in 2024, then jumped by 107.76% to $1.2 million in 2025, then tumbled by 124.92% to -$303000.0 in 2026.
- Per Business Quant, the three latest CRBU Change in Cash figures stand at -$303000.0 (Q1 2026), $1.2 million (Q4 2025), and -$14.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -303,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -303,000.00 |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | -14.06 Mn |
| Jun 30, 2025 | -4.22 Mn |
| Mar 31, 2025 | 13.12 Mn |
| Dec 31, 2024 | -15.68 Mn |
| Sep 30, 2024 | -5.90 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | -52.90 Mn |
| Sep 30, 2023 | 37.86 Mn |
| Jun 30, 2023 | 13.45 Mn |
| Mar 31, 2023 | -5.59 Mn |
| Dec 31, 2022 | -23.75 Mn |
| Sep 30, 2022 | -30.06 Mn |
| Jun 30, 2022 | -35.48 Mn |
| Mar 31, 2022 | -92.79 Mn |
| Dec 31, 2021 | -194.89 Mn |
| Sep 30, 2021 | 305.79 Mn |
| Jun 30, 2021 | -16.35 Mn |
| Mar 31, 2021 | 129.97 Mn |
| Dec 31, 2020 | -8.59 Mn |
| Sep 30, 2020 | -8.58 Mn |